pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,408 catalysts · 7,021 phase readout · 2,430 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: earnings×type: adcom×clear all
type
  • phase readout7,021
  • 8k filing2,430
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

8
›COMPLETEDphase readoutNCT06522906: Mobilizing Hispanics With Knee Osteoarthritis

Sponsor: University of Arizona. Phase: NA. Conditions: Osteoarthritis, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT06994806: A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Solid Tumor Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07040904: Mindfulness to Enhance Cognitive Health in Latino Older Adults

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Mindfulness, Alzheimer's Disease Related Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05668884: GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Sponsor: Fudan University. Phase: PHASE2. Conditions: Biliary Tract Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07604584: Effects of Platelet-Rich Fibrin After Mandibular Third Molar Surgery in Smokers and Nonsmokers

Sponsor: Ankara University. Phase: NA. Conditions: Impacted Mandibular Third Molar, Postoperative Pain, Trismus, Facial Swelling

full page →ctgov ↗
›COMPLETEDphase readoutNCT04287049: A Study of Standard Drugs for Mycobacterium Avium Complex

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Mycobacterium Avium Complex

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07564349: Comparison of 7-Day ECG Patches

Sponsor: Medical University Innsbruck. Phase: NA. Conditions: Atrial Fibrillation (AF), Cardiac Arrhythmias

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583238: Diathermy On Diabetes Glucose Monitoring Effectiveness

Sponsor: University of Nottingham. Phase: . Conditions: Type 1 Diabetes Mellitis

full page →ctgov ↗
← prev
page 149 of 149
next →